Referred to the House Committee on Energy and Commerce.
This bill reauthorizes and expands a federal program supporting State maternal mortality review committees, requires the HHS/CDC to annually disseminate maternal mortality prevention best practices to hospitals, state professional societies, and perinatal quality collaboratives, and strengthens coordination to improve death-record quality (including amending cause-of-death information). It updates membership language to include clinical specialties, and increases authorized funding to $100 million per year for fiscal years 2025–2029.
Supporters emphasize improved data and prevention; opponents stress federal overreach.
Relative to its intended legislative type, this bill is a straightforward substantive reauthorization that also creates an annual dissemination obligation and updates statutory text.
This bill reauthorizes and expands a federal program supporting State maternal mortality review committees, requires the HHS/CDC to annually disseminate maternal mortality prevention best practices to hospitals, state professional societies, and perinatal quality collaboratives, and strengthens coordination to improve death-record quality (including amending cause-of-death information).
It updates membership language to include clinical specialties, and increases authorized funding to $100 million per year for fiscal years 2025–2029.
Narrow, technical public health reauthorization with modest funding is historically likely to advance and be enacted.
Relative to its intended legislative type, this bill is a straightforward substantive reauthorization that also creates an annual dissemination obligation and updates statutory text. It clearly integrates into the existing statutory structure and sets explicit funding authorizations.
Supporters emphasize improved data and prevention; opponents stress federal overreach.
These are examples from the analysis, not a ranked list of the most-affected groups.
Supporters emphasize improved data and prevention; opponents stress federal overreach.
Likely viewed favorably as a targeted federal investment to reduce maternal deaths and improve data-driven prevention.
Supporters would emphasize strengthened review processes, annual dissemination of best practices, and increased funding as steps to address maternal mortality.
Seen as a pragmatic, incremental federal health measure improving surveillance and guidance on maternal mortality.
Generally supportive if costs are justified and there are measurable outcomes and limited federal overreach into state processes.
Likely cautious or skeptical due to expanded federal spending and stronger CDC/HHS roles.
Some conservatives may accept targeted support for maternal safety but resist perceived federal intrusion into state death records and medical practice.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, technical public health reauthorization with modest funding is historically likely to advance and be enacted.
The bill has not accumulated any surfaced votes yet.
Supporters emphasize improved data and prevention; opponents stress federal overreach.
Narrow, technical public health reauthorization with modest funding is historically likely to advance and be enacted.
Relative to its intended legislative type, this bill is a straightforward substantive reauthorization that also creates an annual dissemination obligation and updates statutory text. It clearly integrates into the exist…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.